Evidence map›Paper›PMID 33494357›Full record

ArticleInternational journal of environmental research and public health2021

Real-World Data and Machine Learning to Predict Cardiac Amyloidosis.

Elena García-García, Gracia María González-Romero, Encarna M Martín-Pérez, Enrique de Dios Zapata Cornejo, Gema Escobar-Aguilar, Marlon Félix Cárdenas Bonnet

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Elena García-GarcíaFundación San Juan de Dios, Centro CC de la Salud San Rafael, Universidad Nebrija, 28036 Madrid, Spain.ORCID 0000-0001-5817-1126
Gracia María González-RomeroFundación San Juan de Dios, Centro CC de la Salud San Rafael, Universidad Nebrija, 28036 Madrid, Spain.ORCID 0000-0002-1461-9766
Encarna M Martín-PérezHospital San Juan de Dios de León, 24010 León, Spain.ORCID 0000-0002-1774-9064
Enrique de Dios Zapata CornejoSopra Steria, 28050 Madrid, Spain.ORCID 0000-0001-5589-6295
Gema Escobar-AguilarFundación San Juan de Dios, Centro CC de la Salud San Rafael, Universidad Nebrija, 28036 Madrid, Spain.ORCID 0000-0002-0764-9211
Marlon Félix Cárdenas BonnetSopra Steria, 28050 Madrid, Spain.
Universidad Nebrija · ESHospital de León · ESUniversidad Internacional De La Rioja · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Cardiac amyloidosis or "stiff heart syndrome" is a rare condition that occurs when amyloid deposits occupy the heart muscle. Many patients suffer from it and fail to receive a timely diagnosis mainly because the disease is a rare form of restrictive cardiomyopathy that is difficult to diagnose, often associated with a poor prognosis. This research analyses the characteristics of this pathology and proposes a statistical learning algorithm that helps to detect the disease. (2) Methods: The hospitalization clinical (medical and nursing ones) records used for this study are the basis of the learning and training techniques of the algorithm. The approach consisted of using the information generated by the patients in each admission and discharge episode and treating it as data vectors to facilitate their aggregation. The large volume of clinical histories implied a high dimensionality of the data, and the lack of diagnosis led to a severe class imbalance caused by the low prevalence of the disease. (3) Results: Although there are few patients with amyloidosis in this study, the proposed approach demonstrates that it is possible to learn from clinical records despite the lack of data. In the validation phase, the algorithm first acted on data from the general study population. It then was applied to a sample of patients diagnosed with heart failure. The results revealed that the algorithm detects disease when data vectors profile each disease episode. (4) Conclusions: The prediction levels showed that this technique could be useful in screening processes on a specific population to detect the disease.

Indexed as

AmyloidosisHeart DiseasesHeart FailureHumansMachine LearningMyocardiumartificial intelligencecardiac amyloidosisheart failuremachine learningpredictive modelsreal-world data (RWD)

Identifiers

PMID33494357
PMCPMC7908075
OpenAlexW3123647640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.